1DAY SOONER ACTION PROJECT INC.

Lobbying for 1DAY SOONER ACTION PROJECT INC. · Nonprofit public health advocacy organization

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Oct 18, 2026.

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 18, 2026

Expenses

$40,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Delaware

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Clinical trial modernization legislation to make clinical trials faster, cheaper, and more efficient, including redlines on and support for Rep. Auchinclosss clinical trial bill, a supporting coalition letter, and introduction of a Senate companion (Sen. Hickenlooper); S. 4440, the Clinical Trial Modernization Act (Sen. Scott), including participant compensation provisions. Inclusion of pregnant individuals in clinical trials, including H.R. 8651, the Advancing Safe Medications for Moms and Babies Act of 2026 (Rep. Castor, Sen. Hickenlooper). FDA Sentinel system and real-world evidence provisions for potential health data legislation (Sen. Young), including an expert discussion with the office. Suggested questions to Senate staff for a hearing with Heidi Overton.

Medical/Disease Research/Clinical Labs

S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with pursuing a letter of support from the Senate to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives

Bills named in this filing 3

S. 4440
Clinical Trial Modernization Act
H.R. 8651
Advancing Safe Medications for Moms and Babies Act of 2026
S. 2333
Pandemic and All-Hazards Preparedness and Response Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.